209 related articles for article (PubMed ID: 23141483)
1. A novel low-energy electrotherapy that terminates ventricular tachycardia with lower energy than a biphasic shock when antitachycardia pacing fails.
Janardhan AH; Li W; Fedorov VV; Yeung M; Wallendorf MJ; Schuessler RB; Efimov IR
J Am Coll Cardiol; 2012 Dec; 60(23):2393-8. PubMed ID: 23141483
[TBL] [Abstract][Full Text] [Related]
2. Multistage electrotherapy delivered through chronically-implanted leads terminates atrial fibrillation with lower energy than a single biphasic shock.
Janardhan AH; Gutbrod SR; Li W; Lang D; Schuessler RB; Efimov IR
J Am Coll Cardiol; 2014 Jan 7-14; 63(1):40-8. PubMed ID: 24076284
[TBL] [Abstract][Full Text] [Related]
3. Progressive implantable cardioverter-defibrillator therapies for ventricular tachycardia: The efficacy and safety of multiple bursts, ramps, and low-energy shocks.
Strik M; Ramirez FD; Welte N; Bonnin T; Abu-Alrub S; Eschalier R; Haïssaguerre M; Ritter P; Ploux S; Bordachar P
Heart Rhythm; 2020 Dec; 17(12):2072-2077. PubMed ID: 32739474
[TBL] [Abstract][Full Text] [Related]
4. [Shock-induced, but not terminated ventricular tachycardia in a patient with implantable defibrillator].
Kühlkamp V; Dörnberger V; Mermi J; Mewis C; Seipel L
Z Kardiol; 1996 May; 85(5):306-11. PubMed ID: 8711942
[TBL] [Abstract][Full Text] [Related]
5. Low-energy multistage atrial defibrillation therapy terminates atrial fibrillation with less energy than a single shock.
Li W; Janardhan AH; Fedorov VV; Sha Q; Schuessler RB; Efimov IR
Circ Arrhythm Electrophysiol; 2011 Dec; 4(6):917-25. PubMed ID: 21980076
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
7. Endocardial pacing, cardioversion and defibrillation using a braided endocardial lead system.
Saksena S; Luceri R; Krol RB; Brownstein S; Burkhardt E; Accorti P; Brewer G; Scott S; Callaghan F; Livingston A
Am J Cardiol; 1993 Apr; 71(10):834-41. PubMed ID: 8456763
[TBL] [Abstract][Full Text] [Related]
8. An in-silico assessment of efficacy of two novel intra-cardiac electrode configurations versus traditional anti-tachycardia pacing therapy for terminating sustained ventricular tachycardia.
Qian S; Connolly A; Mendonca-Costa C; Campos F; Williams SE; Whitaker J; Rinaldi CA; Bishop MJ
Comput Biol Med; 2021 Dec; 139():104987. PubMed ID: 34741904
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
10. Survival After Implantable Cardioverter-Defibrillator Shocks.
Aktaş MK; Younis A; Zareba W; Kutyifa V; Klein H; Daubert JP; Estes M; McNitt S; Polonsky B; Goldenberg I
J Am Coll Cardiol; 2021 May; 77(20):2453-2462. PubMed ID: 34016257
[TBL] [Abstract][Full Text] [Related]
11. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
12. Transvenous biventricular defibrillation.
Meisel E; Butter C; Philippon F; Higgins S; Strickberger SA; Smith J; Hahn S; Michel U; Schubert B; Pfeiffer D
Am J Cardiol; 2000 Nov; 86(9A):76K-85K. PubMed ID: 11084104
[TBL] [Abstract][Full Text] [Related]
13. Multiple monophasic shocks improve electrotherapy of ventricular tachycardia in a rabbit model of chronic infarction.
Li W; Ripplinger CM; Lou Q; Efimov IR
Heart Rhythm; 2009 Jul; 6(7):1020-7. PubMed ID: 19560090
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a programming algorithm for the third tachycardia zone in a fourth-generation implantable cardioverter-defibrillator.
Neglia JJ; Krol RB; Giorgberidze I; Mathew P; Lewis C; Munsif AN; Saksena S
J Interv Card Electrophysiol; 1997 Feb; 1(1):49-56. PubMed ID: 9869951
[TBL] [Abstract][Full Text] [Related]
15. Effect of defibrillation threshold testing on heart failure hospitalization or death in the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy (MADIT-CRT).
Aktas MK; Huang DT; Daubert JP; Schuger CD; McNitt S; Goldenberg I; Moss AJ; Zareba W
Heart Rhythm; 2013 Feb; 10(2):193-9. PubMed ID: 23085128
[TBL] [Abstract][Full Text] [Related]
16. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
[TBL] [Abstract][Full Text] [Related]
17. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
[TBL] [Abstract][Full Text] [Related]
18. Implantable transvenous cardioverter-defibrillators.
Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
[TBL] [Abstract][Full Text] [Related]
19. Etiology and Programming Effects on Shock Efficacy in ICD Recipients.
Bertomeu-González V; Moreno-Arribas J; Castillo-Castillo J; Martínez-Ferrer J; Viñolas X; Rodríguez A; Díaz-Infante E; Fernández-Lozano I; Alzueta J; Fontenla A
Pacing Clin Electrophysiol; 2016 Jan; 39(1):73-80. PubMed ID: 26450114
[TBL] [Abstract][Full Text] [Related]
20. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
